论文部分内容阅读
多发性骨髓瘤（ｍｕｌｔｉｐｌｅｍｙｅｌｏｍａ，ＭＭ）是周围血Ｂ细胞肿瘤的一个亚类。ＭＭ主要由成熟和未成熟的浆细胞所组成，其重链和轻链已被重新组合。过去３０多年以来［１］，由于一直使用左旋苯丙酸氮芥（马法兰）及去氢可的松治疗多发性骨髓瘤，病人的预后并未因为
Multiple myeloma (MM) is a subset of peripheral blood B cell tumors. MM consists mainly of mature and immature plasma cells, and its heavy and light chains have been recombined. Over the past 30 years [1], because of the use of levomphenic acid mustard (Mafflin) and dehydrocortisone for the treatment of multiple myeloma, the prognosis of the patient has not been